Letter to the Editor From Rosenfield, et al: "Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome"
J Clin Endocrinol Metab
.
2024 Sep 16;109(10):e1962-e1963.
doi: 10.1210/clinem/dgae368.
Authors
Robert L Rosenfield
1
2
,
Kathryn A Martin
3
,
R Jeffrey Chang
4
,
David A Ehrmann
5
,
Rogerio A Lobo
6
,
Michel M Pugeat
7
Affiliations
1
Departments of Pediatrics and Medicine, The University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA.
2
Department of Pediatrics, The University of California, San Francisco, San Francisco, CA 94143, USA.
3
Department of Medicine, Massachusetts General Hospital, Waltham, MA 02451, USA.
4
Department of Reproductive Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
5
Department of Medicine, The University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA.
6
Department of Obstetrics and Gynecology, Columbia University School of Medicine, New York, NY 10032, USA.
7
CarMen Laboratory, INSERM U1060, Université Claude Bernard Lyon 1, 69600 Oullins, France.
PMID:
38809759
DOI:
10.1210/clinem/dgae368
No abstract available
Keywords:
guidelines; hirsutism; polycystic ovary syndrome.
Publication types
Letter
Editorial
Comment
MeSH terms
Evidence-Based Medicine* / standards
Female
Humans
Polycystic Ovary Syndrome* / diagnosis
Polycystic Ovary Syndrome* / therapy
Practice Guidelines as Topic*